Tandem Diabetes Care Inc

TNDM shows a recent Bullish Pivot Point signaling structural repair, but price remains around the converged 9-EMA and 20-EMA beneath the 50 SMA. Medium-term directional asymmetry favors a mean-reversion buy on this pivot, while short-term timing is neutral as price hovers at the EMAs. Execution should be deferred, stalking for a clean pullback into the EMA zone before engaging.

• ↑Q1 2026 revenue of $247M (+7% YoY) with 29K pumps shipped
• ↑Gross margin improved to 55%, delivering $5M free cash flow
• ↓Supplier capacity constraints causing persistent supply chain bottlenecks